Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on November 22, 2019, 11:42:58 am

Title: 8 Days of Hep C and Cholesterol Meds Blocks Chronic Infection in Transplantees
Post by: Hep Editors on November 22, 2019, 11:42:58 am
The recipients of transplanted organs from donors who had hepatitis C virus (HCV) either cleared or did not acquire the virus when they were treated with just eight days of a combination of direct-acting antivirals (DAAs) and the cholesterol medication Zetia (ezetimibe) in a recent small study.

The treatment was given hours prior to and for seven days following transplantation. Such a rapid treatment greatly lowers the cost of therapy, which typically runs for at least four weeks with a standard DAA regimen for those receiving HCV-infected organ transplants.

Jordan Feld, MD, MPH, the R. Phelan chair in translational liver disease research at the University of Toronto and research director at the Toronto Centre for Liver Disease, presented findings from the study at the Annual Meeting of the American Association for the Study of Liver Diseases in Boston (The Liver Meeting).